ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Conference Call Scheduled for Thursday, May 15, 2025 at 9:00 AM ETPORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2025 after the market closes on Wednesday, May 14, 2025. The Compan ...